and additional information is presented in the research article "Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells" [1] .
& Cell lines were treated with AngII and 6-OHDA. Some cells used were modified genetically.
Experimental features
Effect of Angiotensin II and 6-OHDA in the ROS production, gene expression and survival of different neuronal cell lines. DCFDA (2 0 ,7 0 -dichlorofluorescin-diacetate) was used as a probe for ROS production. Gene expression was estimated with RT-qPCR. MTT The present data on ROS generation could be used as reference for comparison with those of other cells and stressors to better understand effects of antioxidants or reliability of probes.
Cell viability can serve as a starting point for using NRF2 to promote cell survival in oxidative stress conditions.
Gene expression can be used for the design of future experiments targeting the optimal timing for therapies in neurodegenerative diseases and other oxidative stress-associated disorders.
Data
The data presented herein contain gene expression levels of Angiotensin II receptors in dopaminergic cell lines Mes23.5 and N27 (Fig. 1) . We also present data on the fluorescence intensity of DCFDA (i.e. ROS generation) over time in these lines and in the human neuroblastoma SH-SY5Y cell line (Figs. 2, 6 ). We analyzed ROS generation induced by Angiotensin II and/or 6-OHDA, and the corresponding positive and negative controls. Furthermore, we provide data of mRNA expression analysis of genes related to the NRF2 pathway at different time points (Figs. 4-5) . We also show the effects of NRF2 overexpression on the viability of neuronal cell lines treated with Angiotensin II and/or 6-OHDA (Fig. 3) . 
Experimental design, materials and methods

Cell culture
Dopaminergic Mes23.5 cell line, dopaminergic N27 cell line and SH-SY5Y cell line were cultured as previously described [2] [3] [4] . AngII (A9525, Sigma) was used at a concentration of 100 nM 30 min before treatment with the dopaminergic neurotoxin 6-OHDA (0.02% saline ascorbate; H4381 Sigma) when used in combination, except otherwise stated. 6-OHDA was used at a concentration of 10 mM for Mes23.5 or 40 mM for N27 and SH-SY5Y.
HA-NRF2, kindly donated by Dr. Donna D. Zhang (University of Arizona, AZ, USA) was used to infect cell lines. Vectors were transfected into HEK 293 T cells with the corresponding viral packaging plasmids. Viruses were collected from the supernatant and used to infect neuronal cell lines in the presence hexadimethrine bromide (8 mg/ml; H9268, Sigma). Cells were selected with puromycin (10 mg/ml; A11138-03, Thermo Fisher Scientific) starting 72 h after infection. Stable cell lines were established after 2 weeks of selection and were continuously grown in 5 mg/ml of puromycin afterwards.
Cell viability measurement
Cell viability was assessed 24 h after the last treatment: cultures were incubated with MTT (0.5 mg/ml; M2128, Sigma) for 4 h at 37°C. Culture supernatant was then carefully removed and the formazan crystals resulting from cellular dehydrogenases were dissolved in acidic isopropanol and quantified at 570 nm using a plate reader (Infinite M200, Tecan, Grödig, Austria) after gentle shaking. The absorbances were expressed as percentage of control. 
RNA extraction and real-time quantitative RT-PCR
Total ribonucleic acid (RNA) was extracted from cell lines using Trizol (15596-026, Thermo Fisher Scientific). Equal amounts of RNA (2 mg) were reverse-transcribed to complementary DNA with Moloney murine leukemia virus reverse transcriptase (MMLV; 200 U; 28025-013, Thermo Fisher Scientific) following manufacturer's instructions. PCR using real-time iCycler PCR platform (Bio-Rad, Madrid, Spain) in combination with iQ SYBR Green Supermix (#1708882, BioRad) were used to assess expression of Nrf2, Nqo1, Hmox1 or Klf9, AT1 or AT2 using Actin as housekeeping gene. Primer sequences are for rat Hmox1
Total RNA (without reverse transcription) was used as a negative control. Relative mRNA expression was calculated by using comparative cycle threshold (2 À ΔΔCt ) method and the relative amount of mRNA was presented in the form of fold change over control.
Measurement of ROS
Cellular ROS measurement was determined using 2 0 ,7 0 -dichlorofluorescin-diacetate (DCFDA). Cultured cells were washed and loaded with DCFDA (20 mM; D6883, Sigma) for 30 min at 37°C. Basal fluorescence was measured at this time (time ¼ 0) using a plate reader (Tecan Infinite M200) at excitation 485 nm/emission 520 nm. Fluorescence was again measured 15 min, 30 min, 45 min, 60 min, 75 min and 120 min after addition of different treatments. AngII (100 nM) and 6-OHDA (40 mM) were added at the same time in these experiments. N-Acetyl-L-cysteine (NAC, 600 mM; A7250, Sigma) was used as an antioxidant and control for low ROS generation, and hydrogen peroxide (H 2 O 2 , 100 mM; 1.07209.0250, Millipore) was used as a control for high ROS generation. Fluorescent and pLV-KLF9 vector (KLF9) on the ROS production was assessed in neuronal cell lines loaded with the probe DCFDA and fluorescence was measured in a plate reader after 60 min. KLF9 expression had no effect on ROS production after 100 nM AngII treatment but greatly reduced ROS levels in response to 6OHDA or a combination of AngII and 6OHDA in Mes23. intensity was expressed as relative units (RU) calculated as the difference from time 0, normalized relative to control at 15 min.
Statistical analysis
All data were obtained from at least three separated experiments, with a minimum sample size of four wells per group and per experiment. Data were expressed as percentage of the control group of the same batch (i.e. they were expressed relative to the value obtained for the control; 100%) and expressed as a mean 7standard error of the mean (SEM). Data from two groups were analyzed by Mann-Whitney Rank sum test and multiple comparisons were analyzed with one-way ANOVA or two-way ANOVA followed by Holm Sidak test. Differences at p o 0.05 were considered as statistically significant. Statistical analyses and graph design were carried out with SigmaPlot 11.0 (Systat Software, GmbH, Erkrath, Germany) except otherwise stated.
